Safe vincristine use in Switzerland: Still a long way to go?

Lea Domenica Brühwiler David L B Schwappach

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

International recommendations are not widely implemented in Swiss hospitals. Syringes are still in use and other safety measures are sparsely disseminated. Thus, Swiss vincristine patients are still at an increased risk for wrong route application. Recommendations have to be further disseminated and implementation could be enhanced.

Keyphrases

end stage renal disease
healthcare
ejection fraction
chronic kidney disease
primary care
clinical practice
peritoneal dialysis
prognostic factors
patient reported